Alk-Abello AS (WBO:ALKB) Total Liabilities: €364.0 Mil (As of Mar. 2026)


WBO:ALKB Alk-Abello AS WBO:ALKB
66 GF Score
Price €34.22
GF Value €27.26
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Alk-Abello AS Total Liabilities?

Alk-Abello AS WBO:ALKB -0.12% 66 Total Liabilities is €364.0 Mil as of Mar. 2026. GuruFocus rates WBO:ALKB with a GF Score™ of 66/100 and a GF Value™ of €27.26 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Alk-Abello AS's Total Liabilities for the quarter that ended in Mar. 2026 was €364.0 Mil.

Alk-Abello AS's quarterly Total Liabilities increased from Sep. 2025 (€308.30 Mil) to Dec. 2025 (€349.72 Mil) and increased from Dec. 2025 (€349.72 Mil) to Mar. 2026 (€364.05 Mil).

Alk-Abello AS's annual Total Liabilities increased from Dec. 2023 (€305.77 Mil) to Dec. 2024 (€385.24 Mil) but then declined from Dec. 2024 (€385.24 Mil) to Dec. 2025 (€349.72 Mil).

Alk-Abello AS Total Liabilities Historical Data

* Premium members only.

The historical data trend for Alk-Abello AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alk-Abello AS Total Liabilities Chart

Alk-Abello AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 316.02 311.85 305.77 385.24 349.72

Alk-Abello AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 336.79 325.06 308.30 349.72 364.05
WBO:ALKB
66GF Score
Alk-Abello AS WBO:ALKB
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alk-Abello AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Alk-Abello AS's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=177.939+(47.531+69.087
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+32.669+22.493)
=349.7

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1212.636-862.917
=349.7

Alk-Abello AS's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=191.857+(46.693+70.106
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+32.913+22.493)
=364.0

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1242.92-878.874
=364.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €364.0 Mil mean?
Alk-Abello AS (WBO:ALKB) has a Total Liabilities of €364.0 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Alk-Abello AS and its competitors.
Is Alk-Abello AS's Total Liabilities too high?
Alk-Abello AS's current Total Liabilities is €364.0 Mil. Overall, Alk-Abello AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Total Liabilities compare to VRTX and REGN?
Alk-Abello AS's Total Liabilities of €364.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Alk-Abello AS and its competitors. Alk-Abello AS's current Total Liabilities is €364.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (WBO:ALKB) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.26, compared to a current price of €34.22 — trading 25.5% above its estimated fair value. The current Total Liabilities is €364.0 Mil. Alk-Abello AS's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Alk-Abello AS (WBO:ALKB), the current Total Liabilities is €364.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of €34.22 is trading 25.5% above its estimated GF Value™ of €27.26. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for WBO:ALKB:

  • Total Liabilities: €364.0 Mil
  • GF Value™: €27.26 vs. price of €34.22 (25.5% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score

Get the complete analysis for WBO:ALKB

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.22
Price
€27.26
GF Value